Doctors see Eli Lilly’s Mounjaro and Novo Nordisk’s Wegovy as important ammunitions in the anti-obesity treatment.
However, experts also point out the risk of the drug being misused by many — especially young adults — amplied by aggressive marketing, widespread social media promotions and a growing peer pressure driven by the weight loss fad.
Mumbai: India’s warehousing industry is witnessing a green transformation, driven not just by developers and investors but increasingly by multinational…
